[DPHARMA] QoQ Quarter Result on 30-Sep-2021 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
18-Nov-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Sep-2021 [#3]
Profit Trend
QoQ- 10.22%
YoY- 20.08%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 181,742 185,941 145,444 171,838 155,439 166,454 134,086 22.54%
PBT 21,473 26,646 17,128 22,483 20,197 23,176 20,471 3.24%
Tax -5,162 -6,355 -1,412 -5,520 -4,807 -5,562 -4,278 13.37%
NP 16,311 20,291 15,716 16,963 15,390 17,614 16,193 0.48%
-
NP to SH 16,311 20,291 15,716 16,963 15,390 17,614 16,193 0.48%
-
Tax Rate 24.04% 23.85% 8.24% 24.55% 23.80% 24.00% 20.90% -
Total Cost 165,431 165,650 129,728 154,875 140,049 148,840 117,893 25.41%
-
Net Worth 634,375 621,987 621,564 612,147 614,350 635,424 642,484 -0.84%
Dividend
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Div 4,734 - 16,951 - 3,530 - 42,361 -76.89%
Div Payout % 29.02% - 107.86% - 22.94% - 261.60% -
Equity
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Net Worth 634,375 621,987 621,564 612,147 614,350 635,424 642,484 -0.84%
NOSH 952,239 941,765 941,765 941,765 706,330 706,026 706,026 22.13%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 8.97% 10.91% 10.81% 9.87% 9.90% 10.58% 12.08% -
ROE 2.57% 3.26% 2.53% 2.77% 2.51% 2.77% 2.52% -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
RPS 19.19 20.03 15.44 18.25 22.01 23.58 18.99 0.70%
EPS 1.72 2.19 1.67 1.80 2.18 2.49 2.29 -17.41%
DPS 0.50 0.00 1.80 0.00 0.50 0.00 6.00 -81.00%
NAPS 0.67 0.67 0.66 0.65 0.87 0.90 0.91 -18.50%
Adjusted Per Share Value based on latest NOSH - 941,765
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
RPS 18.89 19.33 15.12 17.86 16.16 17.30 13.94 22.52%
EPS 1.70 2.11 1.63 1.76 1.60 1.83 1.68 0.79%
DPS 0.49 0.00 1.76 0.00 0.37 0.00 4.40 -76.94%
NAPS 0.6595 0.6466 0.6462 0.6364 0.6387 0.6606 0.6679 -0.84%
Price Multiplier on Financial Quarter End Date
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Date 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 -
Price 1.20 1.49 1.68 1.81 3.03 2.75 3.38 -
P/RPS 6.25 7.44 10.88 9.92 13.77 11.66 17.80 -50.32%
P/EPS 69.66 68.17 100.67 100.49 139.03 110.23 147.37 -39.40%
EY 1.44 1.47 0.99 1.00 0.72 0.91 0.68 65.13%
DY 0.42 0.00 1.07 0.00 0.17 0.00 1.78 -61.91%
P/NAPS 1.79 2.22 2.55 2.78 3.48 3.06 3.71 -38.56%
Price Multiplier on Announcement Date
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Date 16/08/22 17/05/22 15/02/22 18/11/21 17/08/21 03/05/21 22/02/21 -
Price 1.34 1.51 1.60 1.62 2.49 2.93 3.42 -
P/RPS 6.98 7.54 10.36 8.88 11.31 12.43 18.01 -46.93%
P/EPS 77.78 69.08 95.88 89.94 114.25 117.44 149.11 -35.27%
EY 1.29 1.45 1.04 1.11 0.88 0.85 0.67 54.95%
DY 0.37 0.00 1.13 0.00 0.20 0.00 1.75 -64.61%
P/NAPS 2.00 2.25 2.42 2.49 2.86 3.26 3.76 -34.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment